Hutch News

Hutch News

Stories tagged 'Peter Nelson'

Dr. Joachim Deeg named Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair for Cancer Research

Endowment will support future research for myelodysplastic syndromes

Oct. 18, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Joachim Deeg, a clinical researcher at Fred Hutch who studies myelodysplastic syndromes, has been named the Miklos and Natalia Zimonyi Kohary Endowed Chair for Cancer Research.

View story >


Rolling up the miles for cancer research

Obliteride riders, walkers top $2 million in Fred Hutch fundraiser

Aug. 14, 2018 | By Sabin Russell / Fred Hutch News Service

Nearly 2,300 bicyclists and hikers raised more than $2 million for Fred Hutch research on Saturday's sixth annual Obliteride.

View story >


Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >


'Movember' a reminder for dudes to go to the doctor

Growing facial hair in November part of spotlight on men’s health awareness — and the lack thereof

Nov. 28, 2017 | By Diane Mapes / Fred Hutch News Service

Many men loathe going to the doctor — often to their detriment — but the global organization Movember is trying to change that by encouraging men to grow mustaches (or “mo’s”) during November to raise awareness and funds for men’s health research. Fred Hutch's Dr. Pete Nelson weighs in.

View story >


Targeted therapies push metastatic prostate cancer in new directions

Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments

Nov. 14, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Pete Nelson and colleagues found that as hormone-targeting treatments grow more potent, recurrent prostate tumors are more often finding a new way around the drugs.

View story >


Removing barriers to precision treatment of metastatic prostate cancer

GENTleMEN study aims to help men with advanced disease access genetic testing and counseling

Oct. 30, 2017 | By Sabrina Richards / Fred Hutch News Service

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.